Real-World Persistence and Treatment Interval in Patients with Diabetic Macular Edema Treated with Anti-Vascular Endothelial Growth Factors in the USA

INTRODUCTION: There is little understanding of long-term treatment persistence in patients receiving anti-vascular endothelial growth factor (anti-VEGF) injections for diabetic macular edema (DME), particularly relating to treatment intervals. The aim of this study was to investigate the association...

Descripción completa

Detalles Bibliográficos
Autores principales: Bakri, Sophie J., Delyfer, Marie-Noelle, Grauslund, Jakob, Andersen, Steffen, Karcher, Helene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441838/
https://www.ncbi.nlm.nih.gov/pubmed/37347405
http://dx.doi.org/10.1007/s40123-023-00750-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441838/
https://www.ncbi.nlm.nih.gov/pubmed/37347405
http://dx.doi.org/10.1007/s40123-023-00750-9

Ejemplares similares